607 related articles for article (PubMed ID: 30267888)
1. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
[TBL] [Abstract][Full Text] [Related]
2. Scalable Purification of Plasmid DNA Nanoparticles by Tangential Flow Filtration for Systemic Delivery.
Liu HW; Hu Y; Ren Y; Nam H; Santos JL; Ng S; Gong L; Brummet M; Carrington CA; Ullman CG; Pomper MG; Minn I; Mao HQ
ACS Appl Mater Interfaces; 2021 Jul; 13(26):30326-30336. PubMed ID: 34162211
[TBL] [Abstract][Full Text] [Related]
3. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
[TBL] [Abstract][Full Text] [Related]
4. Continuous Production of Discrete Plasmid DNA-Polycation Nanoparticles Using Flash Nanocomplexation.
Santos JL; Ren Y; Vandermark J; Archang MM; Williford JM; Liu HW; Lee J; Wang TH; Mao HQ
Small; 2016 Dec; 12(45):6214-6222. PubMed ID: 27717227
[TBL] [Abstract][Full Text] [Related]
5. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.
He Z; Santos JL; Tian H; Huang H; Hu Y; Liu L; Leong KW; Chen Y; Mao HQ
Biomaterials; 2017 Jun; 130():28-41. PubMed ID: 28359018
[TBL] [Abstract][Full Text] [Related]
6. Kinetic Control in Assembly of Plasmid DNA/Polycation Complex Nanoparticles.
Hu Y; He Z; Hao Y; Gong L; Pang M; Howard GP; Ahn HH; Brummet M; Chen K; Liu HW; Ke X; Zhu J; Anderson CF; Cui H; Ullman CG; Carrington CA; Pomper MG; Seo JH; Mittal R; Minn I; Mao HQ
ACS Nano; 2019 Sep; 13(9):10161-10178. PubMed ID: 31503450
[TBL] [Abstract][Full Text] [Related]
7. Serum-resistant lipopolyplexes for gene delivery to liver tumour cells.
García L; Buñuales M; Düzgüneş N; Tros de Ilarduya C
Eur J Pharm Biopharm; 2007 Aug; 67(1):58-66. PubMed ID: 17321729
[TBL] [Abstract][Full Text] [Related]
8. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
9. In vivo time-dependent gene expression of cationic lipid-based emulsion as a stable and biocompatible non-viral gene carrier.
Kwon SM; Nam HY; Nam T; Park K; Lee S; Kim K; Kwon IC; Kim J; Kang D; Park JH; Jeong SY
J Control Release; 2008 May; 128(1):89-97. PubMed ID: 18384902
[TBL] [Abstract][Full Text] [Related]
10. Liposome-mediated DNA immunisation via the subcutaneous route.
Perrie Y; McNeil S; Vangala A
J Drug Target; 2003; 11(8-10):555-63. PubMed ID: 15203925
[TBL] [Abstract][Full Text] [Related]
11. Cationic lipid polymerization as a novel approach for constructing new DNA delivery agents.
Wu J; Lizarzaburu ME; Kurth MJ; Liu L; Wege H; Zern MA; Nantz MH
Bioconjug Chem; 2001; 12(2):251-7. PubMed ID: 11312686
[TBL] [Abstract][Full Text] [Related]
12. Characterization and in vivo performance of dextran-spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically.
Eliyahu H; Joseph A; Schillemans JP; Azzam T; Domb AJ; Barenholz Y
Biomaterials; 2007 May; 28(14):2339-49. PubMed ID: 17298842
[TBL] [Abstract][Full Text] [Related]
13. Scalable production of core-shell nanoparticles by flash nanocomplexation to enhance mucosal transport for oral delivery of insulin.
He Z; Liu Z; Tian H; Hu Y; Liu L; Leong KW; Mao HQ; Chen Y
Nanoscale; 2018 Feb; 10(7):3307-3319. PubMed ID: 29384554
[TBL] [Abstract][Full Text] [Related]
14. Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform.
Bailey-Hytholt CM; Ghosh P; Dugas J; Zarraga IE; Bandekar A
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720139
[TBL] [Abstract][Full Text] [Related]
15. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
Zhang J; Haas RM; Leone AM
Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
[TBL] [Abstract][Full Text] [Related]
16. Biophysical properties and supramolecular structure of self-assembled liposome/ε-peptide/DNA nanoparticles: correlation with gene delivery.
Yan J; Korolev N; Eom KD; Tam JP; Nordenskiöld L
Biomacromolecules; 2012 Jan; 13(1):124-31. PubMed ID: 22066663
[TBL] [Abstract][Full Text] [Related]
17. Lipopolyplexes as nanomedicines for therapeutic gene delivery.
García L; Urbiola K; Düzgüneş N; Tros de Ilarduya C
Methods Enzymol; 2012; 509():327-38. PubMed ID: 22568913
[TBL] [Abstract][Full Text] [Related]
18. Effective nanoparticle-based gene delivery by a protease triggered charge switch.
Gjetting T; Jølck RI; Andresen TL
Adv Healthc Mater; 2014 Jul; 3(7):1107-18. PubMed ID: 24652709
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-lipid nanoparticles (CS-LNPs): Application to siRNA delivery.
Tezgel Ö; Szarpak-Jankowska A; Arnould A; Auzély-Velty R; Texier I
J Colloid Interface Sci; 2018 Jan; 510():45-56. PubMed ID: 28934610
[TBL] [Abstract][Full Text] [Related]
20. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
